Education
About Us
Working with TipRanks
Follow Us
Sanofi (SNY)
NASDAQ:SNY
SNY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$45.80 - $60.12
Previous CloseN/A
Volume824.98K
Average Volume (3M)1.95M
Market Cap
$118.00B
Enterprise Value$114.83B
Total Cash (Recent Filing)$7.99B
Total Debt (Recent Filing)€21.05B
Price to Earnings (P/E)20.2
Beta0.47
Next Earnings
Jul 31, 2025EPS Estimate
0.96Last Dividend Ex-Date
May 09, 2025Dividend Yield4.56%
Share Statistics
EPS (TTM)0.79
Shares Outstanding2,455,511,000
10 Day Avg. Volume1,660,722
30 Day Avg. Volume1,948,239
Financial Highlights & Ratios
PEG Ratio1.23
Price to Book (P/B)1.39
Price to Sales (P/S)0.00
P/FCF Ratio64.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$61.20Price Target Upside25.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Sanofi News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRobust sales from key products and new launches propelled earnings above expectations.
Product DevelopmentContinued innovation and strategic focus underpin a confident earnings outlook for 2025.
Product PortfolioSanofi holds a diverse pipeline and is expected to launch or expand indications for over 10 drugs in FY25.
Bears Say
Market CompetitionCompetition from alternatives of Dupixent could risk its market share being diminished.
Product SafetyQfitlia requires liver tests and monitoring for signs and symptoms of acute and recurrent gallbladder disease, indicating potential safety concerns.
Revenue ForecastCompetition and other factors could cap potential revenue for Qfitlia at roughly €350MM in 2030.
Ownership Overview
―
Insiders
4.05% Mutual Funds
0.06% Other Institutional Investors
95.68% Public Companies and Individual Investors
SNY FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest stock price was $45.80 and its highest was $60.12 in the past 12 months.
What is Sanofi’s market cap?
Sanofi’s market cap is $118.00B.
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Jul 31, 2025 which is in 12 days.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Apr 24, 2025. The company reported $0.785 earnings per share for the quarter, missing the consensus estimate of $0.929 by -$0.144.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of $2.212 which represents an annual dividend yield of 4.56%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is 0.96.
How many shares outstanding does Sanofi have?
Sanofi has 2,455,511,000 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of $0.785 in its last earnings report, missing expectations of $0.929. Following the earnings report the stock price went up 0.993%.
Which hedge fund is a major shareholder of Sanofi?
Currently, no hedge funds are holding shares in SNY
Sanofi Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$61.20 (25.80% Upside)
$61.20 (25.80% Upside)
Blogger Sentiment
Bullish
SNY Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 0.3%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-0.02%
12-Months-Change
Fundamentals
Return on Equity
7.34%
Trailing 12-Months
Asset Growth
-1.56%
Trailing 12-Months
Company Description
Sanofi
Sanofi (SNY) is a global healthcare leader engaged in the research, development, manufacturing, and marketing of therapeutic solutions. The company operates across various sectors, including pharmaceuticals, vaccines, and consumer healthcare. Sanofi's core products and services include prescription medicines, vaccines for adults and children, and over-the-counter healthcare products. With a robust pipeline and a strategic focus on emerging markets, Sanofi aims to address a wide range of healthcare needs worldwide.
SNY Company Deck
SNY Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Sanofi's Q1 2025 earnings call presented a strong financial and strategic performance, highlighted by significant growth in Dupixent sales and successful new product launches. However, challenges such as foreign exchange impacts and uncertainties in the U.S. flu vaccine market and potential tariffs present some headwinds.Read More>SNY Stock 12 Month Forecast
Average Price Target
$61.20
▲(25.80%Upside)